Emerald Health Therapeutics Announces $10.8 Million Prospectus Sale VICTORIA, British Columbia, Dec. 03, 2018 (GLOBE NEWSWIRE) — Emerald Health Therapeutics, Inc. (TSXV:EMH) (“Emerald” or the “Company”) has entered into...
After sinking more than 25% in October, the Canadian Cannabis LP Index declined another 14.8% in November to 799.72: The index had run up from 2018 lows in mid-August after the announcement of...
TORONTO, Oct. 10, 2018 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (“MediPharm”) (TSXV: LABS) is pleased to announce that it has entered into a Cannabis Concentrate Program Agreement (the “Agreement”)...
Emerald Health Therapeutics Announces Amendment from Health Canada for Pure Sunfarms’ Cultivation License, Expanding Cannabis Production Area to Approximately 550,000 Square Feet in One of the Single Largest Cannabis...
OCS Announces New Supply Agreements With Additional Licensed Producers and Accessories Suppliers September 5, 2018 — Further to the initial supply announcement on August 20, the Ontario Cannabis Store...
This is a copy of the May 6th edition of our weekly Newsletter, which we have been publishing since October, 2015. Friends, With so much interest in the the...
Emerald Health Therapeutics Acquires Cannabis Licensed Producer in Québec New Emerald operation, one of only six licensed producers in Québec, adds indoor growing capacity of approximately 10,000 kg per...
Village Farms International and Emerald Health Therapeutics Announce Cannabis Cultivation License for 1.1 Million ft2 Delta 3 Greenhouse Operation – Unmatched Experience and Expertise and Optimized Facility Design Will...
In 2017, the first two exchange-traded funds (ETF) focused on publicly-traded cannabis stocks emerged, including Horizons Marijuana Life Sciences Index ETF (TSX: HMMJ) (TSX: HMMJ.U) (OTC: HMLSF) in April...
Emerald Health Announces $15 Million Prospectus Sale; Concurrent Secondary Sale VICTORIA, British Columbia, Jan. 03, 2018 (GLOBE NEWSWIRE) — Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (“Emerald” or the...
Despite a flood of supply this month, Canadian LP stock performance stands out so far in October as investors have retreated somewhat from the overall sector. The Cannabis Stock...
Emerald Health Therapeutics Appoints Pharmaceutical Marketing and Biotech Executive Chris Wagner as CEO VICTORIA, British Columbia, Oct. 02, 2017 (GLOBE NEWSWIRE) — Emerald Health Therapeutics Inc. (“EHT”) (TSXV: EMH)...
Horizons Medical Marijuana Life Sciences ETF (TSX: HMMJ) (OTC: HMLSF), the world’s first and still only cannabis ETF, has adjusted its portfolio this month as its benchmark, the North...
Emerald Health Therapeutics Expands its Cannabis Supply with Purchase from Supreme Pharmaceuticals VICTORIA, British Columbia, Sept. 19, 2017 (GLOBE NEWSWIRE) — Emerald Health Therapeutics Inc. (EHT) (TSXV: EMH) (OCTQX:...
After a big 2nd half of 2016 and some strength in early 2017, Canadian LPs were under heavy pressure from April through June following a glut of supply (new...
Canada’s medical cannabis market began as a flower-only market, but, following a court ruling, the licensed producers (LPs) were permitted to begin producing extracts in late 2015. While these products...
In late May, Lift hosted its first Cannabis Business Conference in Toronto. It was a fantastic event that included many thought leaders in North America and covered eight timely and important...
Emerald Health and Village Farms Announce Strategic Venture to Leverage Large-Scale Greenhouse Infrastructure and Cannabis Production Expertise Transformational combination of expert medicinal cannabis grower with a leading North American...
While Health Canada, which provided an update on April 24th, continues to get the official data out to the public very slowly, the patient enrollment growth in the ACMPR...
Emerald Health Announces Increase in Bought Deal to $24.4 Million VICTORIA, BRITISH COLUMBIA–(Marketwired – April 11, 2017) – Emerald Health Therapeutics Inc. (TSXV: EMH) (OTC: TBQBF) (“Emerald” or the...
Let’s face it, when it comes to cannabis stocks, Canada continues to crush the United States, where federal illegality makes it more difficult to operate and to raise capital....
Emerald Provides Corporate Update and Lays out 2017 Growth Initiatives VICTORIA, Feb. 22, 2017 /CNW/ – Emerald Health Therapeutics Inc. (TSXV: EMH) (OTC: TBQBF) ((“Emerald” or the “Company”) provides...
After a boom in the stock prices of Canadian licensed producers (LPs) in 2016 that left the average stock up more than 355%, the sector is performing very well...
Emerald Announces Closing of $13.8 Million Bought Deal VICTORIA, Feb. 10, 2017 /CNW/ – Emerald Health Therapeutics Inc. (TSXV: EMH) (“Emerald” or the “Company”) is pleased to announce the closing...
Statement from Health Canada on the Testing of Cannabis for Medical Purposes for Unauthorized Pest Control Products OTTAWA, Feb. 7, 2017 /CNW/ – Recently, two licensed producers of cannabis...
